Epigenetics describes how heritable changes in gene expression occur without altering the underlying DNA sequence. These changes are carried by chemical and structural modifications—collectively called epigenetic marks—that influence whether genes are active or silent. Landmark experiments by Randy L. Jirtle at Duke University using the agouti mouse model showed that maternal diet could shift offspring coat color and disease susceptibility through changes in DNA methylation, providing direct evidence that environmental factors can reprogram gene activity without mutation. Andrew P. Feinberg at Johns Hopkins University has documented widespread epigenetic alterations in cancer, demonstrating how disrupted epigenetic regulation contributes to human disease.
Molecular mechanisms
Three principal molecular mechanisms mediate epigenetic control. DNA methylation typically involves adding methyl groups to cytosine bases in CpG-rich regions, often reducing transcription when present near gene promoters. Histone modifications such as acetylation and methylation change how tightly DNA is packaged around histone proteins, altering chromatin accessibility and therefore transcriptional activity. Non-coding RNAs, including microRNAs and long non-coding RNAs, guide chromatin modifiers to specific loci or directly regulate messenger RNA stability. Chromatin remodelers mobilize nucleosomes to expose or hide regulatory DNA sequences. Together these processes form dynamic regulatory layers: some epigenetic marks are stable across cell divisions, while others respond rapidly to cellular signaling.
Environmental drivers and consequences
Environmental exposures are major drivers of epigenetic change. Nutritional components like folate and other methyl donors influence DNA methylation patterns, as demonstrated by Jirtle’s maternal diet experiments. Chemical exposures such as tobacco smoke, air pollution, and endocrine-disrupting compounds have been associated with altered epigenetic profiles and downstream changes in gene expression. Michael K. Skinner at Washington State University has reported that certain toxicant exposures in rodents can produce epigenetic changes that persist across multiple generations, highlighting a potential pathway for non-genetic inheritance; the extent and mechanisms of such transgenerational effects in humans remain contested and under active investigation.
Altered epigenetic states can have broad consequences. In cancer, Andrew P. Feinberg described how both global hypomethylation and focal hypermethylation can activate oncogenes or silence tumor suppressors, respectively. Epigenetic dysregulation is also implicated in metabolic disease, neurodevelopmental disorders, and aging-related functional decline. Cultural, socioeconomic, and territorial contexts shape exposure patterns: communities with higher pollution burden or limited access to nutritious foods may experience different epigenetic impacts, linking social determinants to molecular biology.
Understanding epigenetics has pragmatic implications for medicine and public health. Because some epigenetic modifications are reversible, they are attractive targets for therapies and biomarkers for early disease detection. At the same time, ethical and policy considerations arise around interventions that could alter heritable regulatory states. Rigorous, replicated human studies and transparent engagement with affected communities are essential to translate mechanistic insight into equitable, evidence-based action.